Developed in collaboration with Physicians and researchers
SmartSleep was founded in 10 years of sleep research by industry leading experts and supported by four years of Philips research and development. Since its inception, Philips has worked closely with a scientific advisory board made up of world-renown sleep physicians and scientists. These experts have played a vital role in SmartSleep’s end-to-end innovation, advising Philips development teams on the science behind the functionality, as well as the design and analysis of experimental trials of SmartSleep in the laboratory and in the home.
Scientific advisory board
David P. White, MD
Philips Chief Scientific Officer and Professor at Harvard Medical School
Eve Van Cauter, PhD
Professor; Department of Medicine - Section of Endocrinology, Diabetes and Metabolism; Committee on Molecular Metabolism; Committee of Clinical and Translational Science at University of Chicago
David Dinges, PhD
Professor and Chief, Division of Sleep and Chronobiology, Department of Psychiatry, Perelman School of Medicine, University of Pennsylvania
Thomas Roth, PhD
Director of Sleep Disorders and Research Center at Henry Ford Hospital
Robert Stickgold, PhD
Associate Professor of Psychiatry and Director, Center for Sleep and Cognition, Harvard Medical School
Giulio Tononi, MD, PhD
Professor, Director of the Wisconsin Institute for Sleep and Consciousness, University of Wisconsin – Madison School of Medicine
Phyllis Zee, MD, PhD
Chief of Sleep Medicine in the Department of Neurology, Northwestern University Feinberg School of Medicine
In fact, the need for and approach to developing SmartSleep was primarily born from extensive research by Dr. Giulio Tononi showing that sleep slow waves can be enhanced by the delivery of auditory stimuli. His 2010 paper was a critical catalyst in the conceptualization of SmartSleep as an innovative device to use tonal stimulation to improve deep sleep quality in those who do not get enough sleep due to lifestyle.
At Philips, we see an opportunity to leverage advanced technology, coupled with scientific and consumer insights, to deliver solutions that improve people’s health and drive differentiated outcomes across the health continuum. Our scientific advisory board and the guidance they offer allow us to continue to improve lives through meaningful innovation that is truly rooted in science.
*Serving on Philips Scientific Advisory Board does not indicate direct endorsement of this or any Philips product.
Centers for Disease Control and Prevention. “Effect of Short Sleep on Daily Activities – United States, 2005-2008.” Morbidity and Mortality Weekly Report, vol. 60, no. 8, pp. 239-242, 2011. www.cdc.gov/mmwr/preview/mmwrhtml/mm6008a3.htm
M. Bellesi, B. Riedner, G. Garcia-Molina, C. Cirelli, and G. Tononi. “Enhancement of Sleep Slow Waves: Underlying Mechanisms and Practical Consequences,” Front. Syst. Neurosci., vol. 8, pp 1-17, 2014. doi: 10.3389/fnsys.2014.00208.
Institute of Medicine (US) Committee on Sleep Medicine and Research. “Sleep Disorders and Sleep Deprivation: An Unmet Public Health Problem.” Washington DC: National Academies Press, 2006. Available from: https://www.ncbi.nlm.nih.gov/books/NBK19960/. doi: 10.17226/11617.
† SmartSleep should only be used by people who fall asleep within 30 minutes of trying to fall asleep; sleep at least 5 hours straight but less than 7 hours; don’t regularly wake up during the night; don’t use medications or alcohol to fall asleep and do not have hearing loss. Smartsleep is recommended for use for people 40 years of age and under.
By clicking on the link, you will be leaving the official Royal Philips Healthcare ("Philips") website. Any links to third-party websites that may appear on this site are provided only for your convenience and in no way represent any affiliation or endorsement of the information provided on those linked websites. Philips makes no representations or warranties of any kind with regard to any third-party websites or the information contained therein.